Is thyroiditis a risk factor for cardiac myocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroiditis as a Risk Factor for Cardiac Myocarditis

Yes, thyroiditis can be a risk factor for cardiac myocarditis, with evidence showing that approximately 30% of patients with hyperthyroidism demonstrate cardiovascular magnetic resonance (CMR) findings consistent with myocarditis. 1

Pathophysiological Connection Between Thyroiditis and Myocarditis

Hyperthyroidism-Related Myocarditis

  • In hyperthyroidism (particularly Graves' disease), myocarditis appears to have an autoimmune basis 1
  • CMR studies have demonstrated that 30% of patients with hyperthyroidism show findings consistent with myocarditis, including:
    • Late gadolinium enhancement (LGE)
    • Elevated T2 signal ratios
    • Elevated early gadolinium enhancement (EGE) ratios 1
  • The autoimmune mechanism is supported by the presence of circulating antimicrosomal and antithyroglobulin antibodies 1

Hashimoto's Thyroiditis Connection

  • Case reports have documented sudden cardiac death due to lymphocytic myocarditis associated with Hashimoto's thyroiditis 2
  • The inflammatory pattern in the heart can mirror that found in the thyroid gland, suggesting a shared autoimmune pathophysiology 2
  • Cardiac immunological and histological patterns similar to those found in the thyroid suggest an autoimmune myocarditis mechanism 2

Diagnostic Evidence of the Connection

Cardiovascular Magnetic Resonance (CMR) Findings

  • CMR is the most sensitive imaging modality for identifying myocardial involvement in thyroiditis 1
  • Key findings include:
    • Nonischemic late gadolinium enhancement
    • Prolonged native T1 and T2 relaxation times
    • Evidence of myocardial edema 1

Laboratory Markers

  • Elevated cardiac troponins may be present in patients with thyroiditis who develop myocarditis 3
  • Inflammatory markers are often elevated in both conditions 4
  • Thyroid function tests showing thyrotoxicosis or hypothyroidism should prompt consideration of potential cardiac involvement 4

Clinical Implications and Management

Risk Assessment

  • Patients with thyroiditis, particularly those with hyperthyroidism, should be evaluated for potential cardiac involvement 1
  • The presence of persistent myocardial inflammatory infiltrates by immunohistological evidence or abnormal localized fibrosis by CMR after acute myocarditis may indicate increased risk of sudden cardiac death 1

Treatment Considerations

  • Management of the underlying thyroid disorder is essential 3
  • In cases of autoimmune myocarditis associated with thyroiditis, glucocorticoid therapy may be beneficial 3, 4
  • Standard heart failure therapy may be required for patients with reduced ejection fraction 1
  • ICD implantation may be considered for patients with giant cell myocarditis or sarcoidosis who had hemodynamically compromising sustained ventricular arrhythmias 1

Monitoring and Follow-up

  • Regular cardiac assessment in patients with thyroiditis, especially those with symptoms suggesting cardiac involvement
  • Periodic echocardiography to evaluate ventricular function
  • CMR for tissue characterization when myocarditis is suspected
  • Monitoring of cardiac biomarkers and inflammatory markers

Caveats and Pitfalls

  • Not all patients with thyroiditis will develop myocarditis
  • The connection appears stronger with autoimmune forms of thyroiditis (Graves' disease, Hashimoto's)
  • Symptoms of myocarditis may be subtle or masked by thyroid dysfunction
  • Other causes of myocarditis (viral, other autoimmune conditions) should be ruled out before attributing it to thyroiditis
  • The risk may persist even after achieving euthyroid status, requiring ongoing cardiac monitoring

Animal models have demonstrated a potential shared pathogenic mechanism between autoimmune myocarditis and autoimmune thyroiditis, further supporting this clinical association 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Myocarditis associated with Hashimoto's disease: a case report.

International journal of legal medicine, 2003

Research

Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.

Frontiers in cardiovascular medicine, 2021

Research

Subacute Thyroiditis and Heart Failure in a Patient Presenting With COVID-19.

Journal of investigative medicine high impact case reports, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.